Skip to main content

Appendix DAPC Study Participating Institutions and Investigators

From: Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study)

Investigator

Institution

Japan

 

   Goto T

Department of Internal Medicine, Japanese Red Cross Akita Hospital, Akita

   Imano A

Department of Internal Medicine, Osaka Kouseinenkin Hospital, Osaka, Japan

   Jinnouchi H

Department of Internal Medicine, Jinnouchi Hospital, Kumamoto, Japan

   Kanazawa A

Department of Internal Medicine, Division of Metabolism and Endocrinology, Juntendo University School of Medicine, Tokyo, Japan

   Kasayama S

Department of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

   Kosugi K

Department of Internal Medicine, Osaka Police Hospital, Osaka, Japan

   Matsuoka T

Kurashiki Life Style Disease Center, Okayama, Japan

   Nakato T

Department of Internal Medicine, Okayama Saiseikai General Hospital, Okayama, Japan

   Ono T

Department of Diabetes and Endocrine, Iwaki Kyoritsu Hospital, Fukushima, Japan

   Ota M

Department of Comprehensive Medical Care, Ota Nishinouchi Hospital, Fukushima

   Seino H

Center of Diabetes, Ota Nishinouchi Hospital, Fukushima, Japan

   Sumiya T

Department of Endocrine and Diabetes, NTT West Osaka Hospital, Osaka, Japan

   Yagi M

Department of Endocrinology and Metabolism, Belland General Hospital, Osaka, Japan

   Yamasaki Y*

Department of Endocrine and Metabolic Internal Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

Korea

 

   Chung MY

Department of Internal Medicine, Chonnam National University College of Medicine, Gwangju, Korea

   Kim YS*

Department of Internal Medicine, Kyunghee University College of Medicine, Seoul, Korea

   Lee HC

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

   Soon KH

Department of Internal Medicine, Keimyung University College of Medicine, Daegu, Korea

   Yoon KH

Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea

Philippines

 

   Ganzon MS

Department of Vascular Medicine, Heart Institute, St. Luke’s Medical Center, Manila, Philippines

China

 

   Guo X

Department of Endocrinology, Peking University First Hospital, Beijing, China

  1. *Study director